Kidney failure, also known as renal failure, is a serious medical condition where the kidneys are no longer able to filter waste products from the blood. There are two main types of kidney failure: oliguric and anuric. Oliguric kidney failure is characterized by a decrease in the amount of urine produced, while anuric kidney failure is characterized by the complete absence of urine production. In this article, we will take a closer look at the differences between oliguric and anuric kidney failure.
Oliguric kidney failure is a type of acute kidney injury (AKI) that is characterized by a decrease in the amount of urine produced. This decrease in urine output is usually less than 400 milliliters per day. Oliguric kidney failure can be caused by a variety of factors, including dehydration, certain medications, and certain diseases. It can also be caused by certain types of kidney damage, such as glomerulonephritis or renal artery stenosis. When oliguric kidney failure occurs, the kidneys are unable to filter waste products from the blood. This can lead to an accumulation of toxins in the blood, which can cause a variety of symptoms. These symptoms can include fatigue, confusion, nausea, vomiting, and shortness of breath. If left untreated, oliguric kidney failure can be life-threatening.
Anuric kidney failure is a type of acute kidney injury (AKI) that is characterized by the complete absence of urine production. This means that no urine is produced by the kidneys, regardless of how much fluid is consumed. Anuric kidney failure can be caused by a variety of factors, including dehydration, certain medications, and certain diseases. It can also be caused by certain types of kidney damage, such as glomerulonephritis or renal artery stenosis. When anuric kidney failure occurs, the kidneys are unable to filter waste products from the blood. This can lead to an accumulation of toxins in the blood, which can cause a variety of symptoms. These symptoms can include fatigue, confusion, nausea, vomiting, and shortness of breath. If left untreated, anuric kidney failure can be life-threatening.
Oliguric and anuric kidney failure can be diagnosed by a variety of tests. These tests can include a physical examination, blood tests, urine tests, and imaging tests. The physical examination can help to identify any signs or symptoms of kidney failure, such as swelling or changes in skin color. Blood tests can help to measure levels of waste products in the blood, such as creatinine and urea. Urine tests can help to measure levels of waste products in the urine, such as creatinine and urea. Imaging tests, such as an ultrasound, can help to identify any structural changes in the kidneys.
The treatment of oliguric and anuric kidney failure depends on the underlying cause. If the cause is dehydration, then the patient may be given intravenous fluids to help restore fluid balance. If the cause is a medication, then the medication may be stopped or changed. If the cause is a disease, then the patient may be given medication to help control the disease. In some cases, dialysis may be necessary to help filter waste products from the blood.
Oliguric and anuric kidney failure are serious medical conditions that can be life-threatening if left untreated. Oliguric kidney failure is characterized by a decrease in the amount of urine produced, while anuric kidney failure is characterized by the complete absence of urine production. Both types of kidney failure can be diagnosed by a variety of tests, including physical examination, blood tests, urine tests, and imaging tests. The treatment of oliguric and anuric kidney failure depends on the underlying cause. It is important for patients to seek medical attention if they are experiencing any signs or symptoms of kidney failure.
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
Team finds broken 'brake' on cancer mutation machine.
3.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
New Research on Craniopharyngioma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
The Mysterious World of Petechiae: Exploring Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation